These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 23123655

  • 1. The use of Resolor (prucalopride) for chronic constipation in women.
    Woodward S.
    Br J Nurs; ; 21(16):982, 984-6. PubMed ID: 23123655
    [Abstract] [Full Text] [Related]

  • 2. Prucalopride for the treatment of women with chronic constipation in whom standard laxative regimens have failed to provide adequate relief.
    Pennant M, Orlando R, Barton P, Bayliss S, Routh K, Meads C.
    Health Technol Assess; 2011 May; 15 Suppl 1():43-50. PubMed ID: 21609652
    [Abstract] [Full Text] [Related]

  • 3. [Evaluation of the efficacy of prucalopride (resolor) in the treatment of patients with chronic constipation].
    Osipenko MF, Bikbulatova EA, Skalinskaia MA, Kulygina IuA, Pankova LIu.
    Ter Arkh; 2013 May; 85(12):60-4. PubMed ID: 24640670
    [Abstract] [Full Text] [Related]

  • 4. [Some practical questions on chronic stipsis treatment with prucalopride].
    Bellacosa L, Cogliandro R, Cremon C, De Giorgio R, Barbara G, Stanghellini V.
    Minerva Gastroenterol Dietol; 2014 Mar; 60(1):85-99. PubMed ID: 24632771
    [Abstract] [Full Text] [Related]

  • 5. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives.
    Tack J, van Outryve M, Beyens G, Kerstens R, Vandeplassche L.
    Gut; 2009 Mar; 58(3):357-65. PubMed ID: 18987031
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. What role for prucalopride in constipation?
    Drug Ther Bull; 2011 Aug; 49(8):93-6. PubMed ID: 21831905
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prucalopride. In chronic constipation: poorly documented risks.
    Prescrire Int; 2011 May; 20(116):117-20. PubMed ID: 21648173
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Randomised clinical trial: macrogol/PEG 3350+electrolytes versus prucalopride in the treatment of chronic constipation -- a comparison in a controlled environment.
    Cinca R, Chera D, Gruss HJ, Halphen M.
    Aliment Pharmacol Ther; 2013 May; 37(9):876-86. PubMed ID: 23480216
    [Abstract] [Full Text] [Related]

  • 18. prucalopride (Resolor°) and chronic constipation in men: Avoid in both men and women.
    Prescrire Int; 2016 Oct; 25(175):234. PubMed ID: 30645825
    [Abstract] [Full Text] [Related]

  • 19. The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation.
    Gale JD.
    Adv Ther; 2009 May; 26(5):519-30. PubMed ID: 19444393
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.